Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus.
Gallichan
W S
WS
Department of Pathology, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada.
Johnson
D C
DC
Graham
F L
FL
Rosenthal
K L
KL
D000260:Adenoviruses, Human / Q000235:genetics*; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000956:Antigens, Viral / Q000008:administration & dosage / Q000235:genetics; D005260:Female; D005822:Genetic Vectors; D018259:Herpesvirus 1, Human / Q000235:genetics / Q000276:immunology*; D018258:Herpesvirus 2, Human / Q000276:immunology; D018928:Immunity, Mucosal; D007114:Immunization; D051379:Mice; D008810:Mice, Inbred C57BL; D011995:Recombination, Genetic; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014759:Viral Envelope Proteins / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D014759:Viral Envelope Proteins; C040495:glycoprotein B, Simplexvirus